S212: A RANDOMIZED DOUBLE-BLIND PHASE 3 STUDY OF JAKTINIB VERSUS HYDROXYUREA IN PATIENTS WITH INTERMEDIATE-2 OR HIGH RISK MYELOFIBROSIS

Detalles Bibliográficos
Autores principales: Zhang, Yi, Zhou, Hu, Zhuang, Junling, He, Aili, LI, Yarong, Yang, Linhua, Du, Xin, Gao, Sujun, He, Guangsheng, Hong, Mei, Jiang, Qian, Jiang, Zhongxing, Kai, Sun, Yue, Lingling, Zheng, Cuiping, Zhou, Zeping, Jin, Chenghao, Jing, Hongmei, Liu, Lin, Liu, Qingchi, Wang, Jishi, Wu, Wen, Xu, Yajing, Wu, Dengshu, Xu, Na, Zhang, Feng, Zhang, Jin, Zhu, Huanling, Xiao, Zhijian, Jin, Jie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Oral Sessions
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428257/
http://dx.doi.org/10.1097/01.HS9.0000967760.70775.53

Ejemplares similares

Ejemplares similares